Lifeboat Foundation

What follows is my position piece for London’s FutureFest 2013, the website for which no longer exists.

Medicine is a very ancient practice. In fact, it is so ancient that it may have become obsolete. Medicine aims to restore the mind and body to their natural state relative to an individual’s stage in the life cycle. The idea has been to live as well as possible but also die well when the time came. The sense of what is ‘natural’ was tied to statistically normal ways of living in particular cultures. Past conceptions of health dictated future medical practice. In this respect, medical practitioners may have been wise but they certainly were not progressive.

However, this began to change in the mid-19th century when the great medical experimenter, Claude Bernard, began to champion the idea that medicine should be about the indefinite delaying, if not outright overcoming, of death. Bernard saw organisms as perpetual motion machines in an endless struggle to bring order to an environment that always threatens to consume them. That ‘order’ consists in sustaining the conditions needed to maintain an organism’s indefinite existence. Toward this end, Bernard enthusiastically used animals as living laboratories for testing his various hypotheses.

Historians identify Bernard’s sensibility with the advent of ‘modern medicine’, an increasingly high-tech and aspirational enterprise, dedicated to extending the full panoply of human capacities indefinitely. On this view, scientific training trumps practitioner experience, radically invasive and reconstructive procedures become the norm, and death on a physician’s watch is taken to be the ultimate failure. Humanity 2.0 takes this way of thinking to the next level, which involves the abolition of medicine itself. But what exactly would that mean – and what would replace it?

Continue reading “The Abolition of Medicine as a Goal for Humanity 2.0” »

By Brendan I. Koerner - Wired

Because it’s so late on a Monday afternoon, there is a listless vibe inside the University of Washington lecture hall where Jim Olson is about to speak. The audience consists of a few dozen grad students struggling with end-of-day fatigue. They scarf down free chocolate-chunk cookies as they prepare to take notes, but sugar can sharpen mental alertness only so much. The talk they’ve come to hear, part of a biweekly series on current topics in neuroscience, doesn’t exactly seem like edge-of-your-seat material.

Olson’s first slide wakes them up. It is a pixelated photograph of an adorable 6-year-old boy named Hayden Strum, who sports a white Quiksilver T-shirt and a pirate-style eye patch. Hayden, who suffered from a pernicious brain tumor, came to Olson in 1995, back when Olson was just starting his career as a pediatric oncologist and cancer researcher. For four years, the doctor treated Hayden with successive rounds of chemotherapy and major surgeries, but nothing could save the boy’s life. Olson tells the audience that while sitting in the back row at Hayden’s memorial service, listening to the speakers express their pain, he had an epiphany about his scientific priorities.

Read more

We live in world, where technological advances continually allow new and provocative opportunities to deeply explore every aspect of our existence. Understanding the human brain remains one of our most important challenges– but with 100 billion neurons to contend with, the painstakingly slow progress can give the impression that we may never succeed. Brain mapping research unlocks secrets to our mental, social and physical wellness.

In our upcoming releases for the Galactic Public Archives, noted American PhD Neuroscientist and Futurist, Ken Hayworth outlines why he feels that mapping the brain will not be a quixotic task. Through this, he reveals his unconventional plan to ensure humanity’s place in the universe—forever.

We admit to teasing you with the below link in preparation for the main events.

Singularity University

In the last century, breakthroughs in modern medicine have driven big gains in quality and length of life. Antibiotics, immunization, imaging and radiology, complex surgery, minimally invasive surgery—and more. It’s a long, impressive list.

But what will the next hundred years bring?

Read more

It needs an effort dwarfing all past peace-time and war-time efforts to be launched immediately, which prospect appears almost infinitely unlikely to be met in time.

The outbreak has long surpassed the threshold of instability and can only be spatially contained any more by the formation of uninfected (A) areas as large as possible and infected areas (B) as small as still possible. Water, food, gowns and disinfectants must be provided by international teams immediately in exponentially growing numbers and for whole countries. A supportive industry must be set in motion in a planet-wide action.

The bleak prospect that the quenching of the disease is close to a point of no return stems from chaos theory which is essentially a theory of exponential growth (of differences in the initial conditions). “Exponential growth” means that a level that has been reached – in terms of the number of infected persons in the present case – will double after a constant number of time units for a long time to come. Here, we have an empirical doubling every 3 weeks for 5 months in a row by now with no abating in sight. See the precise graphs at the end of: http://en.wikipedia.org/wiki/Ebola_virus_epidemic_in_West_Africa

Written By: Steven Kotler — Sigularity Hub

Brain implants here we come.

DARPA just announced the ElectRX program, a $78.9 million attempt to develop miniscule electronic devices that interface directly with the nervous system in the hopes of curing a bunch of chronic conditions, ranging from the psychological (depression, PTSD) to the physical (Crohn’s, arthritis). Of course, the big goal here is to usher in a revolution in neuromodulation—that is, the science of modulating the nervous system to fix an underlying problem.

Read more

Continue reading “Open Source SynBio?” »

Ariel Schwartz — Fast Company

BPM 31510 is just another cancer drug in human development trials, except for one thing. Scientists didn’t toil away in labs to come up with it; artificial intelligence did.

The cancer drug development process is costly and time-consuming. On average, it takes 24 to 48 months and upwards of $100 million to find a suitable candidate. Add that to the fact that 95% of all potential drugs fail in clinical trials, and the inefficiencies of the whole drug-discovery machine really become apparent.

Backed by real estate billionaire Carl Berg, eponymous biotech startup Berg wants to use artificial intelligence to design cancer drugs that are cheaper, have fewer side effects, and can be developed in half the time it normally takes. BPM 31510 is the first of Berg’s drugs to get a real-world test.

Read more

By Suzanne Jacobs — MIT Technology Review

Last week Google and Novartis announced that they’re teaming up to develop contact lenses that monitor glucose levels and automatically adjust their focus. But these could be just the start of a clever new product category. From cancer detection and drug delivery to reality augmentation and night vision, our eyes offer unique opportunities for both health monitoring and enhancement.

“Now is the time to put a little computer and a lot of miniaturized technologies in the contact lens,” says Franck Leveiller, head of research and development in the Novartis eye care division.

Read more